Core Viewpoint - The announcement details the extension of the judicial freezing period and the new court-ordered freezing of shares held by Gome Electrical Appliances, a significant shareholder of Beijing Zhongguancun Science and Technology Development (Holding) Co., Ltd. [1] Group 1: Shareholding Information - Gome Electrical Appliances holds 50,000,000 circulating shares of the company, representing 6.64% of the total shares [1] - As of July 31, 2025, the total number of shares frozen and the number of shares subject to court-ordered freezing are reported, although specific figures are not disclosed in the provided text [2] Group 2: Judicial Freezing Details - The shares held by Gome Electrical Appliances have been subject to an extension of the judicial freezing period and additional court-ordered freezing due to ongoing legal matters [4] - The number of shares frozen has been affected by the passive disposal of shares, which reduced the frozen quantity by 807,055 shares as of July 9, 2025 [1] Group 3: Company Governance and Impact - The extension of the judicial freezing and the new court-ordered freezing will not lead to a change in the company's control as of the announcement date [3] - The company maintains independence in its operations, assets, and finances from its controlling shareholder and its concerted actors [3]

Group 1 - The core viewpoint highlights the significant growth and development of the artificial intelligence (AI) industry in Zhongguancun Science City, with 70% of AI unicorn companies located in the area and a total of 1,900 AI enterprises in Haidian District [1] - Zhongguancun Science City has seen the establishment of 12 industrial parks, including a future energy industrial park, and has facilitated financing of 944 million yuan for enterprises through incubators [1][3] - The area is recognized as a global hub for AI talent, with 26 unicorn companies and 6,902 new technology enterprises established in the first half of the year [1] Group 2 - The AI public computing power platform ecosystem has been launched in Beijing, which is essential for AI development, while a high-end data labeling demonstration base has been established in Zhongguancun Science City [2] - Various national-level demonstration application bases for AI in education, law, and medicine are accelerating in Haidian, showcasing successful AI applications that drive innovation in the digital economy [2] - The Zhongguancun Science City Technology Growth Fund has reached a total scale of 20 billion yuan, with investments in 25 sub-funds and 58 direct investment projects amounting to 10.525 billion yuan [2] Group 3 - The area has strengthened enterprise services by collaborating with quality incubation institutions, resulting in the introduction of 86 incubated enterprises and investments in 57 enterprises totaling 696.5 million yuan [3] - New facilities such as the AI Beiwai Community and the Haixing Pharmaceutical Health Innovation Park have been opened to create more development space for technology companies [3] - The "Zhixiaoyu" mini-program has been launched to help enterprises access detailed information about key parks, popular business districts, and quality buildings in Haidian District [3]

Core Viewpoint - The strategic cooperation agreement signed between the Beijing Standardization Research Institute, Beijing Food Inspection Research Institute, and the government of Machangying Town aims to enhance the standardization, inspection, and certification processes for agricultural products, particularly focusing on the "Air Nursery" technology to facilitate the market application of scientific research outcomes [1][2]. Group 1 - The "Air Nursery" technology is being developed in a micro-plant factory in Wangguantun Village, where soil-less and sunlight-free cultivation methods are employed to grow high-tech organic fruits and vegetables [1]. - The products from the "Air Nursery" face challenges in market entry due to the lack of relevant inspection and certification standards, despite their high survival rates and good taste [1][2]. - The agreement will provide a unified standard for testing and certification, which is essential for the successful market introduction of these innovative agricultural products [2]. Group 2 - Standardization and certification are identified as foundational elements for technological innovation and industrial prosperity, enhancing operational efficiency and reliability in the economic system [2]. - The Beijing Inspection and Certification Center plans to collaborate closely with local government and other entities to develop a standard system and improve inspection technology, supporting the growth of high-tech agriculture [2]. - Future projects will include the establishment of a modern food nutrition valley and the development of new functional foods, emphasizing the importance of a robust standardization framework [2].

关于控股股东一致行动人部分股份延长司法再冻结期限及被轮候冻结的公告 共 3 页 证券代码：000931 证券简称：中关村 公告编号：2025-077 北京中关村科技发展（控股）股份有限公司 关于控股股东一致行动人部分股份延长司法再冻结期限及 被轮候冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 近日，北京中关村科技发展（控股）股份有限公司（以下简称：公司）通过 中国证券登记结算有限责任公司查询，获悉： 国美电器有限公司（以下简称：国美电器）作为公司控股股东国美控股集团 有限公司的一致行动人，现持有公司 50,000,000 股流通股，持股比例为 6.64%； 国美电器所持有公司的部分股份被法院延长司法再冻结期限、新增被法院轮候冻 结，具体情况如下： 第 1 页 股东名称 是否为控股股东 或第一大股东及 其一致行动人 司法再冻 结数量 （股） 占其所 持股份 比例 占公 司总 股本 比例 司法再冻 结起始日 原司法再 冻结到期 日 司法再冻结 到期日（延 期后） 司法再冻结 执行人 国美电器 有限公司 是 2,949,853 5.90% 0.39% ...

Group 1 - The company Beijing Zhongguancun Technology Development (Holding) Co., Ltd. has a subsidiary, Beijing Zhongshi New Materials Co., Ltd., which has filed a lawsuit against China State Construction Engineering Corporation due to a sales contract dispute [3][4] - The total amount involved in the lawsuit is RMB 6,447,914.59 [2][7] - The lawsuit is currently in the acceptance stage by the court and has not yet been heard [1][8] Group 2 - The plaintiff, Zhongshi New Materials, claims that the defendant owes RMB 10,245,884.84 for concrete supplied under a contract for a hospital construction project, of which RMB 5,287,867.76 remains unpaid [4][5] - The lawsuit requests the defendant to pay the outstanding amount and overdue interest, totaling RMB 6,447,914.59 [6][7] - The court has scheduled the hearing for August 2025 [3][4] Group 3 - The company has disclosed that there are no other undisclosed litigation or arbitration matters [7] - The impact of the lawsuit on the company's current or future profits is currently indeterminate [2][8] - The company will continue to monitor the lawsuit's progress and will disclose information as required by law [8] Group 4 - Another subsidiary, Shandong Huasu Pharmaceutical Co., Ltd., has obtained a utility model patent certificate from the National Intellectual Property Administration [10][11] - The patent is effective for ten years from the date of application and is expected to enhance the company's intellectual property protection and innovation capabilities [11][12]

证券日报网讯 7月30日晚间，中关村发布公告称，近日，公司下属公司山东华素制药有限公司取得国家 知识产权局颁发的实用新型专利证书。 （文章来源：证券日报） ...

Group 1 - The core point of the article is that Zhongguancun announced the acquisition of a utility model patent for a sodium sulfanilate preparation mixing device by its subsidiary, Shandong Huasu Pharmaceutical Co., Ltd. [2] - In the fiscal year 2024, Zhongguancun's revenue composition is as follows: 74.96% from biomedicine, 17.48% from concrete, 4.94% from elderly health, and 2.62% from other sectors [2]

证券代码：000931 证券简称：中关村 公告编号：2025-076 北京中关村科技发展（控股）股份有限公司 关于下属公司山东华素取得实用新型专利证书的公告 关于下属公司山东华素取得实用新型专利证书的公告 共 1 页 注：专利权自授权公告之日起生效。专利权期限为十年，自申请日起算。 上述实用新型专利不会对公司近期生产经营产生重大影响，但有利于进一步 完善公司知识产权保护体系，充分发挥自主知识产权优势，促进技术创新，形成 持续创新机制，提升公司的综合竞争力。敬请广大投资者注意投资风险。 备查文件 1、国家知识产权局颁发的实用新型专利证书。 特此公告 北京中关村科技发展（控股）股份有限公司 董 事 会 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 近日，北京中关村科技发展（控股）股份有限公司（以下简称：公司）下属 公司山东华素制药有限公司取得国家知识产权局颁发的实用新型专利证书，具体 情况如下： | 实用新型名称 | 专利申请日 | | | | 授权公告日 | | | 专利号 | 授权公告号 | 专利权人 | | --- | --- | --- | --- | ...

关于下属公司提起诉讼的公告 共 3 页 证券代码：000931 证券简称：中关村 公告编号：2025-075 北京中关村科技发展（控股）股份有限公司 关于下属公司提起诉讼的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、案件所处的诉讼阶段：法院已受理，尚未开庭审理。 2、上市公司所处的当事人地位：原告为公司下属公司。 3、涉案的金额：总金额人民币 6,447,914.59 元。 4、对上市公司损益产生的影响：目前案件尚未开庭审理，其对公司本期利 润或期后利润的影响暂时无法判断。 一、本次诉讼事项受理的基本情况 北京中关村科技发展（控股）股份有限公司（以下简称：公司）控股子公司 北京中实混凝土有限责任公司之控股子公司北京中实新材料有限责任公司（以下 简称：中实新材料）向北京市丰台区人民法院递交《民事起诉状》，因买卖合同 纠纷起诉中国建筑一局（集团）有限公司，北京市丰台区人民法院已受理本案， 收到北京市丰台区人民法院《传票》【（2025）京 0106 民初 37635 号】，该案 件将于 2025 年 8 月开庭审理。 中实新材料与被告就北京 ...

Core Viewpoint - The healthcare industry is recognized as a strategic emerging industry in China, facing financing challenges due to long R&D cycles and high investment requirements, prompting Beijing Zhongguancun Bank to develop specialized financial services to support innovation in this sector [1][2][3]. Industry Overview - The healthcare sector is experiencing unprecedented growth driven by factors such as an aging population, increased health awareness, and technological breakthroughs. The Beijing Municipal Government aims for the pharmaceutical and healthcare industry to reach a total scale of 1.25 trillion yuan by 2026 [2]. - The average R&D cycle for innovative drugs is 5-8 years, requiring investments of hundreds of millions to billions of yuan, with a success rate of less than 10%. High-end medical devices also face lengthy commercialization processes, leading to significant financing challenges for companies [2][3]. Company Strategy - Beijing Zhongguancun Bank has focused on the healthcare sector since its establishment in 2017, creating a comprehensive service system to address financing pain points and support industry upgrades [1][4]. - The bank has developed a specialized team with backgrounds in medicine, pharmacy, and bioengineering to enhance credit assessment and review processes [4][5]. Financial Solutions - The bank has introduced innovative financial products tailored to the healthcare sector, such as a "Technology R&D Loan" with a maximum term of 5 years and a "Warrant Loan" that combines debt financing with equity options to mitigate risks [8]. - A proprietary evaluation model has been developed, incorporating AI technology to assess healthcare companies based on their pipeline value, financing health, competitive landscape, and commercialization prospects [7][8]. Ecosystem Development - The bank aims to transform from a mere fund provider to a long-term partner for healthcare companies by building a "financial + ecosystem" service model, collaborating with various stakeholders including investment institutions, hospitals, and research institutions [9][10]. - The bank has supported over 300 healthcare companies in Beijing, with more than 200 receiving credit support totaling nearly 5 billion yuan, with 30% being first-time borrowers [5][10].